Today's FDA news a 'clear negative' for Hims and Hers (HIMS) - BofA Securities
BofA Securities analyst Michael Cherny reiterated an Underperform rating and $21.00 price target on Hims and Hers (NYSE: HIMS) after ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
